SURG vs. CXDO, STCN, GSIT, CODA, MOBX, GCTS, LITB, SPRU, VUZI, and FLUX
Should you be buying SurgePays stock or one of its competitors? The main competitors of SurgePays include Crexendo (CXDO), Steel Connect (STCN), GSI Technology (GSIT), Coda Octopus Group (CODA), Mobix Labs (MOBX), GCT Semiconductor (GCTS), LightInTheBox (LITB), Spruce Power (SPRU), Vuzix (VUZI), and Flux Power (FLUX). These companies are all part of the "computer and technology" sector.
SurgePays (NASDAQ:SURG) and Crexendo (NASDAQ:CXDO) are both small-cap computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, valuation, institutional ownership, dividends, community ranking, risk and analyst recommendations.
SurgePays received 157 more outperform votes than Crexendo when rated by MarketBeat users. Likewise, 68.72% of users gave SurgePays an outperform vote while only 38.46% of users gave Crexendo an outperform vote.
In the previous week, SurgePays had 13 more articles in the media than Crexendo. MarketBeat recorded 15 mentions for SurgePays and 2 mentions for Crexendo. Crexendo's average media sentiment score of 0.61 beat SurgePays' score of 0.16 indicating that Crexendo is being referred to more favorably in the news media.
SurgePays has a beta of 1.11, suggesting that its stock price is 11% more volatile than the S&P 500. Comparatively, Crexendo has a beta of 1.16, suggesting that its stock price is 16% more volatile than the S&P 500.
6.9% of SurgePays shares are held by institutional investors. Comparatively, 9.5% of Crexendo shares are held by institutional investors. 29.4% of SurgePays shares are held by insiders. Comparatively, 56.6% of Crexendo shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
SurgePays presently has a consensus target price of $10.00, suggesting a potential upside of 137.25%. Crexendo has a consensus target price of $6.38, suggesting a potential upside of 62.21%. Given SurgePays' higher probable upside, equities research analysts plainly believe SurgePays is more favorable than Crexendo.
SurgePays has a net margin of 12.93% compared to Crexendo's net margin of 3.01%. SurgePays' return on equity of 55.35% beat Crexendo's return on equity.
SurgePays has higher revenue and earnings than Crexendo. SurgePays is trading at a lower price-to-earnings ratio than Crexendo, indicating that it is currently the more affordable of the two stocks.
Summary
SurgePays beats Crexendo on 10 of the 18 factors compared between the two stocks.
Get SurgePays News Delivered to You Automatically
Sign up to receive the latest news and ratings for SURG and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SURG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
SurgePays Competitors List
Related Companies and Tools
